These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6856650)

  • 21. Antinociceptive effects of stimulation of discrete sites in the rat hypothalamus: evidence for the participation of the lateral hypothalamus area in descending pain suppression mechanisms.
    Franco AC; Prado WA
    Braz J Med Biol Res; 1996 Nov; 29(11):1531-41. PubMed ID: 9196558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose apomorphine attenuates morphine-induced enhancement of brain stimulation reward.
    Knapp CM; Kornetsky C
    Pharmacol Biochem Behav; 1996 Sep; 55(1):87-91. PubMed ID: 8870042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference.
    Bilsky EJ; Marglin SH; Reid LD
    Pharmacol Biochem Behav; 1990 Nov; 37(3):425-31. PubMed ID: 2087483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between morphine and reinforcing lateral hypothalamic stimulation.
    Ornstein K; Huston JP
    Psychopharmacology (Berl); 1977 Nov; 54(3):227-35. PubMed ID: 413137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site-specific naloxone blockade of brain self-stimulation duration.
    Freedman NL; Pangborn D
    Pharmacol Biochem Behav; 1984 Mar; 20(3):361-6. PubMed ID: 6608735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic and rate-suppressing effects of opioid antagonists in the pigeon.
    France CP; Woods JH
    J Pharmacol Exp Ther; 1985 Nov; 235(2):442-7. PubMed ID: 4057080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A within-subject comparison of the effects of morphine on lateral hypothalamic and central gray self-stimulation.
    Schenk S; Coupal A; Williams T; Shizgal P
    Pharmacol Biochem Behav; 1981 Jul; 15(1):37-41. PubMed ID: 7291228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mu and kappa opioid agonists elevate brain stimulation threshold for escape by inhibiting aversion.
    Carr KD; Bonnet KA; Simon EJ
    Brain Res; 1982 Aug; 245(2):389-93. PubMed ID: 6289969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain site variations in effects of morphine on electrical self-stimulation.
    Nelson WT; Steiner SS; Brutus M; Farrell R; Ellman SJ
    Psychopharmacology (Berl); 1981; 74(1):58-65. PubMed ID: 6791206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypothalamic sites sensitive to morphine and naloxone: effects on feeding behavior.
    Woods JS; Leibowitz SF
    Pharmacol Biochem Behav; 1985 Sep; 23(3):431-8. PubMed ID: 4048238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation.
    Reid LD; Hubbell CL; Tsai J; Fishkin MD; Amendola CA
    Pharmacol Biochem Behav; 1996 Feb; 53(2):477-80. PubMed ID: 8808161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphine differentially affects ventral tegmental and substantia nigra brain reward thresholds.
    Nazzaro JM; Seeger TF; Gardner EL
    Pharmacol Biochem Behav; 1981 Mar; 14(3):325-31. PubMed ID: 7232458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites.
    Olds ME; Williams KN
    Brain Res; 1980 Jul; 194(1):155-70. PubMed ID: 7378834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intracranial self-stimulation thresholds: a model for the hedonic effects of drugs of abuse.
    Kornetsky C; Esposito RU; McLean S; Jacobson JO
    Arch Gen Psychiatry; 1979 Mar; 36(3):289-92. PubMed ID: 420547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine-induced potentiation of brain stimulation reward is enhanced by MK-801.
    Carlezon WA; Wise RA
    Brain Res; 1993 Aug; 620(2):339-42. PubMed ID: 8369967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isradipine in combination with naltrexone as a medicine for treating cocaine abuse.
    Reid LD; Pabello NG; Cramer CM; Hubbell CL
    Life Sci; 1997; 60(8):PL119-26. PubMed ID: 9042392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increasing the work requirements lowers the threshold of naloxone for reducing self-stimulation in the midbrain of rats.
    West CH; Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1983 May; 18(5):705-10. PubMed ID: 6856645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 2004 Sep; 175(3):287-95. PubMed ID: 15024547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.